Extracellular
PrivateLast Round
Seed
Mar 27, 2023
Total Funding Raised
$2.48M
Company Overview
Extracellular operates in Healthcare & Life Sciences and is based in Bristol. Its latest recorded funding round was a Seed round in March 2023.
Extracellular is a biotechnology company that provides contract development and manufacturing services for the cultivated meat, seafood, cosmetics, and materials industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Extracellular Comparables
Compare Extracellular with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Newform Foods | 85% | |
| TruMeat | 84% | |
| Innocent Meat | 81% |
For institutional investors. Book with your work email.
Extracellular Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 27, 2023 | ||||
| Accelerator | Oct 4, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Extracellular Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Unruly Capital | Seed |
| Good Startup | Seed |
| Newland Syndicate | Seed |
| Future Food Fund | Seed |
| Future Food Fund | Seed |
| Big Idea Ventures | Seed, Accelerator |
| Tiny Supercomputer Investment Company | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Partnering with the University of Bristol for a 2026 Bioprocessing Bootcamp.
- Sep 15, 2025
Partnering with Roslin Technologies for process innovations at NAPIC Conference.
For institutional investors. Book with your work email.
Extracellular Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Extracellular's valuation, stock price, and market status.
Is Extracellular a public or private company?
Extracellular is a private company.
What is the current stock price of Extracellular?
Extracellular is a private company, so its shares have no public market price. Caplight tracks Extracellular's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Extracellular worth (valuation)?
Valuation information for Extracellular is not publicly available.
Can I buy Extracellular stock?
Extracellular shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Extracellular's last funding round?
Extracellular's most recent funding round was Seed on March 27, 2023.
Who are the main investors in Extracellular?
Key investors in Extracellular include Future Food Fund, Big Idea Ventures.
Will Extracellular IPO soon?
No public IPO plans have been announced for Extracellular.
How can I track Extracellular secondary market activity?
Caplight tracks bids, offers, and trades in Extracellular's shares on secondary markets.